» Articles » PMID: 37370141

Stem Cell-derived Brainstem Mouse Astrocytes Obtain a Neurotoxic Phenotype in Vitro Upon Neuroinflammation

Overview
Publisher Biomed Central
Date 2023 Jun 27
PMID 37370141
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Astrocytes respond to injury and disease through a process known as reactive astrogliosis, of which inflammatory signaling is one subset. This inflammatory response is heterogeneous with respect to the inductive stimuli and the afflicted central nervous system region. This is of plausible importance in e.g. traumatic axonal injury (TAI), where lesions in the brainstem carries a particularly poor prognosis. In fact, astrogliotic forebrain astrocytes were recently suggested to cause neuronal death following axotomy. We therefore sought to assess if ventral brainstem- or rostroventral spinal astrocytes exert similar effects on motor neurons in vitro.

Methods: We derived brainstem/rostroventral spinal astrocyte-like cells (ES-astrocytes) and motor neurons using directed differentiation of mouse embryonic stem cells (ES). We activated the ES-astrocytes using the neurotoxicity-eliciting cytokines interleukin- (IL-) 1α and tumor necrosis factor-(TNF-)α and clinically relevant inflammatory mediators. In co-cultures with reactive ES-astrocytes and motor neurons, we assessed neurotoxic ES-astrocyte activity, similarly to what has previously been shown for other central nervous system (CNS) regions.

Results: We confirmed the brainstem/rostroventral ES-astrocyte identity using RNA-sequencing, immunocytochemistry, and by comparison with primary subventricular zone-astrocytes. Following cytokine stimulation, the c-Jun N-terminal kinase pathway down-stream product phosphorylated c-Jun was increased, thus demonstrating ES-astrocyte reactivity. These reactive ES-astrocytes conferred a contact-dependent neurotoxic effect upon co-culture with motor neurons. When exposed to IL-1β and IL-6, two neuroinflammatory cytokines found in the cerebrospinal fluid and serum proteome following human severe traumatic brain injury (TBI), ES-astrocytes exerted similar effects on motor neurons. Activation of ES-astrocytes by these cytokines was associated with pathways relating to endoplasmic reticulum stress and altered regulation of MYC.

Conclusions: Ventral brainstem and rostroventral spinal cord astrocytes differentiated from mouse ES can exert neurotoxic effects in vitro. This highlights how neuroinflammation following CNS lesions can exert region- and cell-specific effects. Our in vitro model system, which uniquely portrays astrocytes and neurons from one niche, allows for a detailed and translationally relevant model system for future studies on how to improve neuronal survival in particularly vulnerable CNS regions following e.g. TAI.

Citing Articles

Tracing ALS Degeneration: Insights from Spinal Cord and Cortex Transcriptomes.

Sneha N, Dharshini S, Taguchi Y, Gromiha M Genes (Basel). 2024; 15(11).

PMID: 39596631 PMC: 11593627. DOI: 10.3390/genes15111431.


Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury.

Lindblad C, Rostami E, Helmy A Neurotherapeutics. 2023; 20(6):1508-1528.

PMID: 37610701 PMC: 10684479. DOI: 10.1007/s13311-023-01421-0.

References
1.
Durinck S, Spellman P, Birney E, Huber W . Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009; 4(8):1184-91. PMC: 3159387. DOI: 10.1038/nprot.2009.97. View

2.
Bush T, Puvanachandra N, Horner C, Polito A, Ostenfeld T, Svendsen C . Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 1999; 23(2):297-308. DOI: 10.1016/s0896-6273(00)80781-3. View

3.
Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H . Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019; 90(8):870-881. DOI: 10.1136/jnnp-2018-320106. View

4.
Khan S, Joyce J, Tsuda T . Quantification of active and total transforming growth factor-β levels in serum and solid organ tissues by bioassay. BMC Res Notes. 2012; 5:636. PMC: 3556312. DOI: 10.1186/1756-0500-5-636. View

5.
Middeldorp J, Hol E . GFAP in health and disease. Prog Neurobiol. 2011; 93(3):421-43. DOI: 10.1016/j.pneurobio.2011.01.005. View